American Journal of Obstetrics & Gynecology Welcomes New Editors-in-Chief
PHILADELPHIA, September 19, 2013 /PRNewswire/ --
Dr. Ingrid Nygaard and Dr. Roberto Romero appointed Editors-in-Chief of AJOG
The American Journal of Obstetrics & Gynecology (AJOG) today announced with pleasure the appointment of Ingrid Nygaard MD, MS, Professor of Obstetrics and Gynecology at the University of Utah and Roberto Romero, M.D., D.Med.Sci, Chief of the Perinatology Research Branch and Program Head for Perinatal Research and Obstetrics of NICHD/NIH, as the new Editors-in-Chief of AJOG.
Drs. Nygaard and Romero will replace Drs. Thomas Garite and Moon Kim effective January 1, 2014.
Known as the "Gray Journal", AJOG has been a prestigious forum in the field of obstetrics and gynecology for over 100 years, and introduced an innovative print-short/electronic-long format five years ago to meet the needs of its more than 41,000 readers worldwide. With an Impact Factor of 3.877 and an Eigenfactor of 0.05172, AJOG is one of the leading scientific publications in the field of obstetrics and gynecology. AJOG is well-known for its Reports of Major Impact and Clinical Opinions, as well as its original, clinical and translational research, which have changed the lives of women and families.
In their new roles, Drs. Nygaard and Romero will work to strengthen the Journal's scholarly success. Their vision is to grow AJOG into a high quality and high impact journal supported by a robust multimedia online platform with a user-friendly interface.
"Building on the prestige and excellence of AJOG, we are looking forward to introducing innovative methods to convey information about clinical practice and science," said Dr. Romero. "The biomedical journal of the 21st century needs to be timely, efficient, and practical, and use formats that meet the evolving needs of obstetricians, gynecologists, and our patients worldwide."
"By maximizing AJOG's focus on cutting-edge, evidence-based research and reader-friendly data synthesis and presentation, we will work to position the Journal as the leader in disseminating high-quality information in the field of women's health," added Dr. Nygaard.
"Drs. Nygaard and Romero make a strong team and I look forward to working with them to publish the finest work in the field in ways that engage and educate our busy readers," said Andrea Boccelli, Publisher at Elsevier. Elsevier is confident that these two leaders in women's health will succeed in elevating AJOG's already strong standing. Their commitment, skills, and expertise will support the Journal's goal of improving the lives of women and their babies by disseminating the best science to researchers and clinicians."
About American Journal of Obstetrics & Gynecology
AJOG, has been a prestigious forum in obstetrics and gynecology for over 100 years, and is currently read by more than 41,000 obstetricians and gynecologists across the globe. With an impact factor of 3.877 and an Eigenfactor of 0.05172, AJOG is a leading scientific publication in the field of obstetrics and gynecology. For more information, go to: http://www.ajog.org
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).